Results of a phase II trial with cystemustine in advanced malignant melanoma. A trial of the EORTC clinical screening group

Urosevic, V; Chollet, P.; Adenis, Antoine; Chauvergne, J.; Fargeot, P; Roche, H.; Kerbrat, P; Lentz, MA.; Fumoleau, P; Chevallier, B

doi:10.1016/0959-8049(95)00473-4

Results of a phase II trial with cystemustine in advanced malignant melanoma. A trial of the EORTC clinical screening group

Urosevic, V

;

Chollet, P.

;

Adenis, Antoine

;

Chauvergne, J.

;

Chevallier, B

;et.al.

(1996) European Journal of Cancer — Vol. 32A, n° 1, p. 181-182 (1996)

Files

pdfdocument.pdf

Restricted Access
Adobe PDF
278.73 KB

Request a copy

Details

Authors

Urosevic, V
Author
Chollet, P.
Author
Adenis, Antoine
Author
Chauvergne, J.
Author
Chevallier, B
Author

Affiliations

UCLouvain

Citations

APA
Chicago
FWB

Urosevic, V., Chollet, P., Adenis, A., Chauvergne, J., Fargeot, P., Roche, H., Kerbrat, P., Lentz, MA., Fumoleau, P., & Chevallier, B. (1996). Results of a phase II trial with cystemustine in advanced malignant melanoma. A trial of the EORTC clinical screening group. European Journal of Cancer, 32A(1), 181-182. https://doi.org/10.1016/0959-8049(95)00473-4 (Original work published 1996)